TCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE [1].
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
[1]. Yang Yi, et al. Preparation of site-specific antibody conjugates. Patent WO2022037665.
















